Zurich, 18 June 2021 – Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”) has successfully extended the subordinated convertible loan agreement of CHF 900,000 dated 8 March 2021 to CHF 1,650,000 thereby granting Achiko an additional CHF 750,000 to be used on product development, sales … [Read more...]
Achiko announces the successful integration of its Teman Sehat digital ecosystem and AptameX Covid-19 diagnostic testing platform for launch in Indonesia
Wireless integration of AptameX Covid-19 test with Teman Sehat completedTeman Sehat’s open API allows for integration of third party testing platformsTeman Sehat provides results within 15 minutes, permitting entry into safe locationsTesting current Teman Sehat subscribers 3 to 5 times per month … [Read more...]
2021 Annual General Meeting of Achiko AG: Shareholders adopt all proposals
Zurich, 26 May 2021 – Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko” or the “Company”) held its Annual General Meeting today at 10:00 CEST in Zurich. Due to the Covid-19 pandemic, this Annual General Meeting was held without physical presence of the shareholders in accordance with art. 27 … [Read more...]
Achiko completes initial shipment of AptameX, its progressive Covid-19 diagnostic test, to Indonesia, delivering 77% sensitivity at low viral loads
Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day).AptameX delivers sensitivity of 77% (95% CI: 75.94 - 79.24) at a high industry CT score of 28.3, which is comparable to current lateral flow rapid tests.Moving to complete product … [Read more...]
Achiko appoints new Chief Financial Officer and announces changes to senior team
Appoints Robert Rieder as Chief Financial OfficerChief Operating Officer Chris Young to retireFocus on product development, lowering cost profile and improved alignment of resourcesZurich, 4 May 2021 – Achiko AG (SWX:ACHI, ISIN CH0522213468) appoints Robert Rieder as Chief Financial Offer … [Read more...]